From April 1, 2024 to June 30, 2024, the company has repurchased 1,006,000 shares, representing 0.24% for CNY 27.75 million. With this, the company has completed the repurchase of 1,617,267 shares, representing 0.39% for CNY 44.76 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.38 CNY | +1.71% |
|
+3.92% | -25.01% |
02/07 | Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024. | CI |
20/05 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.01% | 138.62Cr | |
+8.54% | 10TCr | |
+11.97% | 4.39TCr | |
-11.76% | 3.32TCr | |
+79.85% | 2.94TCr | |
-12.20% | 1.61TCr | |
+4.00% | 1.47TCr | |
-1.90% | 1.29TCr | |
+178.17% | 1.05TCr | |
+3.30% | 882.97Cr |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.